[
    [
        {
            "time": "2018-01-10",
            "original_text": "Dividend Aristocrats You Never Have to Worry About",
            "features": {
                "keywords": [
                    "Dividend",
                    "Aristocrats"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "finance"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Dividend Aristocrats You Never Have to Worry About",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 5,
                "Duration": 8,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 3,
                "Headline_Structure": 9,
                "Source_Recency": 4
            }
        },
        {
            "time": "2018-01-15",
            "original_text": "See what the IHS Markit Score report has to say about Abbott Laboratories.",
            "features": {
                "keywords": [
                    "IHS Markit Score",
                    "Abbott Laboratories"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "See what the IHS Markit Score report has to say about Abbott Laboratories.",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-03-12",
            "original_text": "Tech Stalwarts Lead the Way: Cramer's 'Mad Money' Recap (Monday 3/12/18)",
            "features": {
                "keywords": [
                    "Tech Stalwarts",
                    "Cramer",
                    "Mad Money"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "technology"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Tech Stalwarts Lead the Way: Cramer's 'Mad Money' Recap (Monday 3/12/18)",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 2,
                "Headline_Structure": 8,
                "Source_Recency": 2
            }
        }
    ]
]